nodes	percent_of_prediction	percent_of_DWPC	metapath
Esomeprazole—CYP2C19—Vismodegib—skin cancer	0.182	0.295	CbGbCtD
Esomeprazole—CYP3A4—Imiquimod—skin cancer	0.127	0.206	CbGbCtD
Esomeprazole—CYP3A4—Temozolomide—skin cancer	0.127	0.206	CbGbCtD
Esomeprazole—CYP3A4—Vismodegib—skin cancer	0.0881	0.143	CbGbCtD
Esomeprazole—CYP3A4—Vemurafenib—skin cancer	0.0697	0.113	CbGbCtD
Esomeprazole—CYP3A4—Docetaxel—skin cancer	0.0239	0.0387	CbGbCtD
Esomeprazole—Rhinitis—Fluorouracil—skin cancer	0.000412	0.00108	CcSEcCtD
Esomeprazole—Dizziness—Vemurafenib—skin cancer	0.00041	0.00107	CcSEcCtD
Esomeprazole—Hypoaesthesia—Fluorouracil—skin cancer	0.000409	0.00107	CcSEcCtD
Esomeprazole—Pharyngitis—Fluorouracil—skin cancer	0.000408	0.00107	CcSEcCtD
Esomeprazole—Immune system disorder—Temozolomide—skin cancer	0.000403	0.00106	CcSEcCtD
Esomeprazole—Mediastinal disorder—Temozolomide—skin cancer	0.000402	0.00105	CcSEcCtD
Esomeprazole—Cough—Bleomycin—skin cancer	0.000402	0.00105	CcSEcCtD
Esomeprazole—Chills—Temozolomide—skin cancer	0.0004	0.00105	CcSEcCtD
Esomeprazole—Ill-defined disorder—Dactinomycin—skin cancer	0.000399	0.00104	CcSEcCtD
Esomeprazole—Anaemia—Dactinomycin—skin cancer	0.000397	0.00104	CcSEcCtD
Esomeprazole—Vomiting—Vemurafenib—skin cancer	0.000394	0.00103	CcSEcCtD
Esomeprazole—Alopecia—Temozolomide—skin cancer	0.000394	0.00103	CcSEcCtD
Esomeprazole—Dry skin—Docetaxel—skin cancer	0.000393	0.00103	CcSEcCtD
Esomeprazole—Myalgia—Bleomycin—skin cancer	0.000392	0.00103	CcSEcCtD
Esomeprazole—Chest pain—Bleomycin—skin cancer	0.000392	0.00103	CcSEcCtD
Esomeprazole—Abdominal pain upper—Docetaxel—skin cancer	0.000392	0.00103	CcSEcCtD
Esomeprazole—Rash—Vemurafenib—skin cancer	0.000391	0.00102	CcSEcCtD
Esomeprazole—Mental disorder—Temozolomide—skin cancer	0.000391	0.00102	CcSEcCtD
Esomeprazole—Dermatitis—Vemurafenib—skin cancer	0.000391	0.00102	CcSEcCtD
Esomeprazole—Hypersensitivity—Imiquimod—skin cancer	0.00039	0.00102	CcSEcCtD
Esomeprazole—Headache—Vemurafenib—skin cancer	0.000389	0.00102	CcSEcCtD
Esomeprazole—Malnutrition—Temozolomide—skin cancer	0.000389	0.00102	CcSEcCtD
Esomeprazole—Breast disorder—Docetaxel—skin cancer	0.000388	0.00102	CcSEcCtD
Esomeprazole—Discomfort—Bleomycin—skin cancer	0.000387	0.00101	CcSEcCtD
Esomeprazole—Malaise—Dactinomycin—skin cancer	0.000387	0.00101	CcSEcCtD
Esomeprazole—Aspartate aminotransferase increased—Docetaxel—skin cancer	0.000386	0.00101	CcSEcCtD
Esomeprazole—Toxic epidermal necrolysis—Docetaxel—skin cancer	0.000386	0.00101	CcSEcCtD
Esomeprazole—Cramp muscle—Docetaxel—skin cancer	0.000386	0.00101	CcSEcCtD
Esomeprazole—Leukopenia—Dactinomycin—skin cancer	0.000385	0.00101	CcSEcCtD
Esomeprazole—Dysgeusia—Temozolomide—skin cancer	0.00038	0.000997	CcSEcCtD
Esomeprazole—Asthenia—Imiquimod—skin cancer	0.00038	0.000994	CcSEcCtD
Esomeprazole—Confusional state—Bleomycin—skin cancer	0.000379	0.000993	CcSEcCtD
Esomeprazole—Alanine aminotransferase increased—Docetaxel—skin cancer	0.000378	0.000991	CcSEcCtD
Esomeprazole—Anaphylactic shock—Bleomycin—skin cancer	0.000376	0.000985	CcSEcCtD
Esomeprazole—Back pain—Temozolomide—skin cancer	0.000376	0.000984	CcSEcCtD
Esomeprazole—Pruritus—Imiquimod—skin cancer	0.000374	0.000981	CcSEcCtD
Esomeprazole—Infection—Bleomycin—skin cancer	0.000373	0.000978	CcSEcCtD
Esomeprazole—Dysphagia—Docetaxel—skin cancer	0.000371	0.000971	CcSEcCtD
Esomeprazole—Nausea—Vemurafenib—skin cancer	0.000369	0.000965	CcSEcCtD
Esomeprazole—Thrombocytopenia—Bleomycin—skin cancer	0.000368	0.000964	CcSEcCtD
Esomeprazole—Vision blurred—Temozolomide—skin cancer	0.000366	0.000959	CcSEcCtD
Esomeprazole—Myalgia—Dactinomycin—skin cancer	0.000366	0.000958	CcSEcCtD
Esomeprazole—Bronchospasm—Docetaxel—skin cancer	0.000365	0.000955	CcSEcCtD
Esomeprazole—Tremor—Temozolomide—skin cancer	0.000364	0.000953	CcSEcCtD
Esomeprazole—Alopecia—Fluorouracil—skin cancer	0.000363	0.000952	CcSEcCtD
Esomeprazole—Diarrhoea—Imiquimod—skin cancer	0.000362	0.000948	CcSEcCtD
Esomeprazole—Discomfort—Dactinomycin—skin cancer	0.000361	0.000946	CcSEcCtD
Esomeprazole—Angina pectoris—Docetaxel—skin cancer	0.000361	0.000946	CcSEcCtD
Esomeprazole—Ill-defined disorder—Temozolomide—skin cancer	0.00036	0.000944	CcSEcCtD
Esomeprazole—Anaemia—Temozolomide—skin cancer	0.000359	0.000941	CcSEcCtD
Esomeprazole—Anorexia—Bleomycin—skin cancer	0.000358	0.000939	CcSEcCtD
Esomeprazole—Agitation—Temozolomide—skin cancer	0.000357	0.000935	CcSEcCtD
Esomeprazole—Angioedema—Temozolomide—skin cancer	0.000355	0.00093	CcSEcCtD
Esomeprazole—Pancytopenia—Docetaxel—skin cancer	0.000352	0.000922	CcSEcCtD
Esomeprazole—Malaise—Temozolomide—skin cancer	0.00035	0.000918	CcSEcCtD
Esomeprazole—Dizziness—Imiquimod—skin cancer	0.00035	0.000916	CcSEcCtD
Esomeprazole—Vertigo—Temozolomide—skin cancer	0.000349	0.000914	CcSEcCtD
Esomeprazole—Infection—Dactinomycin—skin cancer	0.000348	0.000912	CcSEcCtD
Esomeprazole—Leukopenia—Temozolomide—skin cancer	0.000348	0.000911	CcSEcCtD
Esomeprazole—Neutropenia—Docetaxel—skin cancer	0.000347	0.000908	CcSEcCtD
Esomeprazole—Palpitations—Temozolomide—skin cancer	0.000343	0.000899	CcSEcCtD
Esomeprazole—Thrombocytopenia—Dactinomycin—skin cancer	0.000343	0.000899	CcSEcCtD
Esomeprazole—Musculoskeletal discomfort—Bleomycin—skin cancer	0.000342	0.000897	CcSEcCtD
Esomeprazole—Cough—Temozolomide—skin cancer	0.000339	0.000888	CcSEcCtD
Esomeprazole—Paraesthesia—Bleomycin—skin cancer	0.000338	0.000884	CcSEcCtD
Esomeprazole—Weight increased—Docetaxel—skin cancer	0.000337	0.000884	CcSEcCtD
Esomeprazole—Vision blurred—Fluorouracil—skin cancer	0.000337	0.000884	CcSEcCtD
Esomeprazole—Vomiting—Imiquimod—skin cancer	0.000336	0.000881	CcSEcCtD
Esomeprazole—Weight decreased—Docetaxel—skin cancer	0.000335	0.000879	CcSEcCtD
Esomeprazole—Hypertension—Temozolomide—skin cancer	0.000335	0.000879	CcSEcCtD
Esomeprazole—Dyspnoea—Bleomycin—skin cancer	0.000335	0.000878	CcSEcCtD
Esomeprazole—Anorexia—Dactinomycin—skin cancer	0.000334	0.000875	CcSEcCtD
Esomeprazole—Rash—Imiquimod—skin cancer	0.000334	0.000874	CcSEcCtD
Esomeprazole—Dermatitis—Imiquimod—skin cancer	0.000333	0.000873	CcSEcCtD
Esomeprazole—Headache—Imiquimod—skin cancer	0.000331	0.000868	CcSEcCtD
Esomeprazole—Anaemia—Fluorouracil—skin cancer	0.000331	0.000867	CcSEcCtD
Esomeprazole—Arthralgia—Temozolomide—skin cancer	0.000331	0.000866	CcSEcCtD
Esomeprazole—Myalgia—Temozolomide—skin cancer	0.000331	0.000866	CcSEcCtD
Esomeprazole—Infestation NOS—Docetaxel—skin cancer	0.000331	0.000866	CcSEcCtD
Esomeprazole—Infestation—Docetaxel—skin cancer	0.000331	0.000866	CcSEcCtD
Esomeprazole—Anxiety—Temozolomide—skin cancer	0.00033	0.000863	CcSEcCtD
Esomeprazole—Unspecified disorder of skin and subcutaneous tissue—Temozolomide—skin cancer	0.000328	0.00086	CcSEcCtD
Esomeprazole—Stevens-Johnson syndrome—Docetaxel—skin cancer	0.000328	0.000859	CcSEcCtD
Esomeprazole—Discomfort—Temozolomide—skin cancer	0.000327	0.000856	CcSEcCtD
Esomeprazole—Decreased appetite—Bleomycin—skin cancer	0.000327	0.000856	CcSEcCtD
Esomeprazole—Renal failure—Docetaxel—skin cancer	0.000325	0.000851	CcSEcCtD
Esomeprazole—Dry mouth—Temozolomide—skin cancer	0.000323	0.000847	CcSEcCtD
Esomeprazole—Jaundice—Docetaxel—skin cancer	0.000322	0.000844	CcSEcCtD
Esomeprazole—Stomatitis—Docetaxel—skin cancer	0.000322	0.000844	CcSEcCtD
Esomeprazole—Pain—Bleomycin—skin cancer	0.000321	0.000842	CcSEcCtD
Esomeprazole—Conjunctivitis—Docetaxel—skin cancer	0.000321	0.000842	CcSEcCtD
Esomeprazole—Leukopenia—Fluorouracil—skin cancer	0.00032	0.000839	CcSEcCtD
Esomeprazole—Confusional state—Temozolomide—skin cancer	0.00032	0.000837	CcSEcCtD
Esomeprazole—Musculoskeletal discomfort—Dactinomycin—skin cancer	0.000319	0.000837	CcSEcCtD
Esomeprazole—Anaphylactic shock—Temozolomide—skin cancer	0.000317	0.000831	CcSEcCtD
Esomeprazole—Infection—Temozolomide—skin cancer	0.000315	0.000825	CcSEcCtD
Esomeprazole—Nausea—Imiquimod—skin cancer	0.000314	0.000823	CcSEcCtD
Esomeprazole—Hepatobiliary disease—Docetaxel—skin cancer	0.000313	0.000819	CcSEcCtD
Esomeprazole—Epistaxis—Docetaxel—skin cancer	0.000312	0.000817	CcSEcCtD
Esomeprazole—Nervous system disorder—Temozolomide—skin cancer	0.000311	0.000815	CcSEcCtD
Esomeprazole—Thrombocytopenia—Temozolomide—skin cancer	0.00031	0.000813	CcSEcCtD
Esomeprazole—Feeling abnormal—Bleomycin—skin cancer	0.00031	0.000811	CcSEcCtD
Esomeprazole—Agranulocytosis—Docetaxel—skin cancer	0.000309	0.000808	CcSEcCtD
Esomeprazole—Skin disorder—Temozolomide—skin cancer	0.000308	0.000807	CcSEcCtD
Esomeprazole—Hyperhidrosis—Temozolomide—skin cancer	0.000307	0.000803	CcSEcCtD
Esomeprazole—Chest pain—Fluorouracil—skin cancer	0.000305	0.000798	CcSEcCtD
Esomeprazole—Myalgia—Fluorouracil—skin cancer	0.000305	0.000798	CcSEcCtD
Esomeprazole—Decreased appetite—Dactinomycin—skin cancer	0.000305	0.000798	CcSEcCtD
Esomeprazole—Fatigue—Dactinomycin—skin cancer	0.000302	0.000792	CcSEcCtD
Esomeprazole—Anorexia—Temozolomide—skin cancer	0.000302	0.000792	CcSEcCtD
Esomeprazole—Discomfort—Fluorouracil—skin cancer	0.000301	0.000789	CcSEcCtD
Esomeprazole—Pain—Dactinomycin—skin cancer	0.0003	0.000785	CcSEcCtD
Esomeprazole—Urticaria—Bleomycin—skin cancer	0.000299	0.000782	CcSEcCtD
Esomeprazole—Rhinitis—Docetaxel—skin cancer	0.000298	0.000779	CcSEcCtD
Esomeprazole—Body temperature increased—Bleomycin—skin cancer	0.000297	0.000778	CcSEcCtD
Esomeprazole—Hepatitis—Docetaxel—skin cancer	0.000297	0.000777	CcSEcCtD
Esomeprazole—Hypoaesthesia—Docetaxel—skin cancer	0.000295	0.000774	CcSEcCtD
Esomeprazole—Confusional state—Fluorouracil—skin cancer	0.000295	0.000772	CcSEcCtD
Esomeprazole—Pharyngitis—Docetaxel—skin cancer	0.000295	0.000772	CcSEcCtD
Esomeprazole—Urinary tract disorder—Docetaxel—skin cancer	0.000293	0.000768	CcSEcCtD
Esomeprazole—Oedema peripheral—Docetaxel—skin cancer	0.000292	0.000766	CcSEcCtD
Esomeprazole—Anaphylactic shock—Fluorouracil—skin cancer	0.000292	0.000765	CcSEcCtD
Esomeprazole—Connective tissue disorder—Docetaxel—skin cancer	0.000292	0.000764	CcSEcCtD
Esomeprazole—Urethral disorder—Docetaxel—skin cancer	0.000291	0.000762	CcSEcCtD
Esomeprazole—Infection—Fluorouracil—skin cancer	0.00029	0.00076	CcSEcCtD
Esomeprazole—Feeling abnormal—Dactinomycin—skin cancer	0.000289	0.000757	CcSEcCtD
Esomeprazole—Musculoskeletal discomfort—Temozolomide—skin cancer	0.000289	0.000757	CcSEcCtD
Esomeprazole—Insomnia—Temozolomide—skin cancer	0.000287	0.000751	CcSEcCtD
Esomeprazole—Gastrointestinal pain—Dactinomycin—skin cancer	0.000287	0.000751	CcSEcCtD
Esomeprazole—Nervous system disorder—Fluorouracil—skin cancer	0.000287	0.00075	CcSEcCtD
Esomeprazole—Thrombocytopenia—Fluorouracil—skin cancer	0.000286	0.000749	CcSEcCtD
Esomeprazole—Visual impairment—Docetaxel—skin cancer	0.000286	0.000749	CcSEcCtD
Esomeprazole—Tachycardia—Fluorouracil—skin cancer	0.000285	0.000747	CcSEcCtD
Esomeprazole—Paraesthesia—Temozolomide—skin cancer	0.000285	0.000746	CcSEcCtD
Esomeprazole—Dyspnoea—Temozolomide—skin cancer	0.000283	0.00074	CcSEcCtD
Esomeprazole—Somnolence—Temozolomide—skin cancer	0.000282	0.000738	CcSEcCtD
Esomeprazole—Erythema multiforme—Docetaxel—skin cancer	0.000281	0.000735	CcSEcCtD
Esomeprazole—Dyspepsia—Temozolomide—skin cancer	0.000279	0.000731	CcSEcCtD
Esomeprazole—Anorexia—Fluorouracil—skin cancer	0.000278	0.000729	CcSEcCtD
Esomeprazole—Eye disorder—Docetaxel—skin cancer	0.000277	0.000727	CcSEcCtD
Esomeprazole—Abdominal pain—Dactinomycin—skin cancer	0.000277	0.000726	CcSEcCtD
Esomeprazole—Body temperature increased—Dactinomycin—skin cancer	0.000277	0.000726	CcSEcCtD
Esomeprazole—Hypersensitivity—Bleomycin—skin cancer	0.000277	0.000725	CcSEcCtD
Esomeprazole—Decreased appetite—Temozolomide—skin cancer	0.000276	0.000722	CcSEcCtD
Esomeprazole—Flushing—Docetaxel—skin cancer	0.000275	0.000722	CcSEcCtD
Esomeprazole—Gastrointestinal disorder—Temozolomide—skin cancer	0.000274	0.000717	CcSEcCtD
Esomeprazole—Fatigue—Temozolomide—skin cancer	0.000273	0.000716	CcSEcCtD
Esomeprazole—Pain—Temozolomide—skin cancer	0.000271	0.00071	CcSEcCtD
Esomeprazole—Constipation—Temozolomide—skin cancer	0.000271	0.00071	CcSEcCtD
Esomeprazole—Asthenia—Bleomycin—skin cancer	0.00027	0.000706	CcSEcCtD
Esomeprazole—Immune system disorder—Docetaxel—skin cancer	0.000268	0.000702	CcSEcCtD
Esomeprazole—Mediastinal disorder—Docetaxel—skin cancer	0.000267	0.000701	CcSEcCtD
Esomeprazole—Chills—Docetaxel—skin cancer	0.000266	0.000698	CcSEcCtD
Esomeprazole—Musculoskeletal discomfort—Fluorouracil—skin cancer	0.000266	0.000697	CcSEcCtD
Esomeprazole—Pruritus—Bleomycin—skin cancer	0.000266	0.000697	CcSEcCtD
Esomeprazole—Insomnia—Fluorouracil—skin cancer	0.000264	0.000692	CcSEcCtD
Esomeprazole—Paraesthesia—Fluorouracil—skin cancer	0.000262	0.000687	CcSEcCtD
Esomeprazole—Alopecia—Docetaxel—skin cancer	0.000262	0.000687	CcSEcCtD
Esomeprazole—Feeling abnormal—Temozolomide—skin cancer	0.000261	0.000684	CcSEcCtD
Esomeprazole—Dyspnoea—Fluorouracil—skin cancer	0.00026	0.000682	CcSEcCtD
Esomeprazole—Mental disorder—Docetaxel—skin cancer	0.00026	0.000681	CcSEcCtD
Esomeprazole—Somnolence—Fluorouracil—skin cancer	0.00026	0.00068	CcSEcCtD
Esomeprazole—Gastrointestinal pain—Temozolomide—skin cancer	0.000259	0.000679	CcSEcCtD
Esomeprazole—Malnutrition—Docetaxel—skin cancer	0.000258	0.000677	CcSEcCtD
Esomeprazole—Hypersensitivity—Dactinomycin—skin cancer	0.000258	0.000677	CcSEcCtD
Esomeprazole—Dyspepsia—Fluorouracil—skin cancer	0.000257	0.000674	CcSEcCtD
Esomeprazole—Decreased appetite—Fluorouracil—skin cancer	0.000254	0.000665	CcSEcCtD
Esomeprazole—Dysgeusia—Docetaxel—skin cancer	0.000253	0.000663	CcSEcCtD
Esomeprazole—Gastrointestinal disorder—Fluorouracil—skin cancer	0.000252	0.000661	CcSEcCtD
Esomeprazole—Urticaria—Temozolomide—skin cancer	0.000252	0.00066	CcSEcCtD
Esomeprazole—Asthenia—Dactinomycin—skin cancer	0.000252	0.000659	CcSEcCtD
Esomeprazole—Abdominal pain—Temozolomide—skin cancer	0.000251	0.000657	CcSEcCtD
Esomeprazole—Body temperature increased—Temozolomide—skin cancer	0.000251	0.000657	CcSEcCtD
Esomeprazole—Back pain—Docetaxel—skin cancer	0.00025	0.000655	CcSEcCtD
Esomeprazole—Pain—Fluorouracil—skin cancer	0.00025	0.000654	CcSEcCtD
Esomeprazole—Muscle spasms—Docetaxel—skin cancer	0.000248	0.000651	CcSEcCtD
Esomeprazole—Feeling abnormal—Fluorouracil—skin cancer	0.000241	0.000631	CcSEcCtD
Esomeprazole—Diarrhoea—Dactinomycin—skin cancer	0.00024	0.000628	CcSEcCtD
Esomeprazole—Vomiting—Bleomycin—skin cancer	0.000239	0.000626	CcSEcCtD
Esomeprazole—Anaemia—Docetaxel—skin cancer	0.000239	0.000626	CcSEcCtD
Esomeprazole—Rash—Bleomycin—skin cancer	0.000237	0.000621	CcSEcCtD
Esomeprazole—Dermatitis—Bleomycin—skin cancer	0.000237	0.00062	CcSEcCtD
Esomeprazole—Hypersensitivity—Temozolomide—skin cancer	0.000234	0.000612	CcSEcCtD
Esomeprazole—Urticaria—Fluorouracil—skin cancer	0.000232	0.000608	CcSEcCtD
Esomeprazole—Leukopenia—Docetaxel—skin cancer	0.000231	0.000606	CcSEcCtD
Esomeprazole—Body temperature increased—Fluorouracil—skin cancer	0.000231	0.000605	CcSEcCtD
Esomeprazole—Palpitations—Docetaxel—skin cancer	0.000228	0.000598	CcSEcCtD
Esomeprazole—Asthenia—Temozolomide—skin cancer	0.000228	0.000596	CcSEcCtD
Esomeprazole—Cough—Docetaxel—skin cancer	0.000225	0.000591	CcSEcCtD
Esomeprazole—Pruritus—Temozolomide—skin cancer	0.000224	0.000588	CcSEcCtD
Esomeprazole—Nausea—Bleomycin—skin cancer	0.000223	0.000585	CcSEcCtD
Esomeprazole—Hypertension—Docetaxel—skin cancer	0.000223	0.000584	CcSEcCtD
Esomeprazole—Vomiting—Dactinomycin—skin cancer	0.000223	0.000584	CcSEcCtD
Esomeprazole—Rash—Dactinomycin—skin cancer	0.000221	0.000579	CcSEcCtD
Esomeprazole—Arthralgia—Docetaxel—skin cancer	0.00022	0.000576	CcSEcCtD
Esomeprazole—Myalgia—Docetaxel—skin cancer	0.00022	0.000576	CcSEcCtD
Esomeprazole—Chest pain—Docetaxel—skin cancer	0.00022	0.000576	CcSEcCtD
Esomeprazole—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—skin cancer	0.000218	0.000572	CcSEcCtD
Esomeprazole—Diarrhoea—Temozolomide—skin cancer	0.000217	0.000568	CcSEcCtD
Esomeprazole—Hypersensitivity—Fluorouracil—skin cancer	0.000215	0.000564	CcSEcCtD
Esomeprazole—Dry mouth—Docetaxel—skin cancer	0.000215	0.000563	CcSEcCtD
Esomeprazole—Confusional state—Docetaxel—skin cancer	0.000213	0.000557	CcSEcCtD
Esomeprazole—Anaphylactic shock—Docetaxel—skin cancer	0.000211	0.000552	CcSEcCtD
Esomeprazole—Dizziness—Temozolomide—skin cancer	0.00021	0.000549	CcSEcCtD
Esomeprazole—Infection—Docetaxel—skin cancer	0.000209	0.000549	CcSEcCtD
Esomeprazole—Nausea—Dactinomycin—skin cancer	0.000208	0.000545	CcSEcCtD
Esomeprazole—Shock—Docetaxel—skin cancer	0.000207	0.000543	CcSEcCtD
Esomeprazole—Nervous system disorder—Docetaxel—skin cancer	0.000207	0.000542	CcSEcCtD
Esomeprazole—Pruritus—Fluorouracil—skin cancer	0.000207	0.000541	CcSEcCtD
Esomeprazole—Thrombocytopenia—Docetaxel—skin cancer	0.000206	0.000541	CcSEcCtD
Esomeprazole—Tachycardia—Docetaxel—skin cancer	0.000206	0.000539	CcSEcCtD
Esomeprazole—Skin disorder—Docetaxel—skin cancer	0.000205	0.000536	CcSEcCtD
Esomeprazole—Vomiting—Temozolomide—skin cancer	0.000202	0.000528	CcSEcCtD
Esomeprazole—Anorexia—Docetaxel—skin cancer	0.000201	0.000526	CcSEcCtD
Esomeprazole—Rash—Temozolomide—skin cancer	0.0002	0.000524	CcSEcCtD
Esomeprazole—Diarrhoea—Fluorouracil—skin cancer	0.0002	0.000524	CcSEcCtD
Esomeprazole—Dermatitis—Temozolomide—skin cancer	0.0002	0.000523	CcSEcCtD
Esomeprazole—Headache—Temozolomide—skin cancer	0.000199	0.00052	CcSEcCtD
Esomeprazole—Dizziness—Fluorouracil—skin cancer	0.000193	0.000506	CcSEcCtD
Esomeprazole—Musculoskeletal discomfort—Docetaxel—skin cancer	0.000192	0.000503	CcSEcCtD
Esomeprazole—Insomnia—Docetaxel—skin cancer	0.000191	0.0005	CcSEcCtD
Esomeprazole—Paraesthesia—Docetaxel—skin cancer	0.000189	0.000496	CcSEcCtD
Esomeprazole—Nausea—Temozolomide—skin cancer	0.000188	0.000493	CcSEcCtD
Esomeprazole—Dyspnoea—Docetaxel—skin cancer	0.000188	0.000492	CcSEcCtD
Esomeprazole—Somnolence—Docetaxel—skin cancer	0.000187	0.000491	CcSEcCtD
Esomeprazole—Vomiting—Fluorouracil—skin cancer	0.000186	0.000487	CcSEcCtD
Esomeprazole—Dyspepsia—Docetaxel—skin cancer	0.000186	0.000486	CcSEcCtD
Esomeprazole—Rash—Fluorouracil—skin cancer	0.000184	0.000483	CcSEcCtD
Esomeprazole—Dermatitis—Fluorouracil—skin cancer	0.000184	0.000482	CcSEcCtD
Esomeprazole—Decreased appetite—Docetaxel—skin cancer	0.000183	0.00048	CcSEcCtD
Esomeprazole—Headache—Fluorouracil—skin cancer	0.000183	0.000479	CcSEcCtD
Esomeprazole—Gastrointestinal disorder—Docetaxel—skin cancer	0.000182	0.000477	CcSEcCtD
Esomeprazole—Fatigue—Docetaxel—skin cancer	0.000182	0.000476	CcSEcCtD
Esomeprazole—Pain—Docetaxel—skin cancer	0.00018	0.000472	CcSEcCtD
Esomeprazole—Constipation—Docetaxel—skin cancer	0.00018	0.000472	CcSEcCtD
Esomeprazole—Feeling abnormal—Docetaxel—skin cancer	0.000174	0.000455	CcSEcCtD
Esomeprazole—Nausea—Fluorouracil—skin cancer	0.000174	0.000455	CcSEcCtD
Esomeprazole—Gastrointestinal pain—Docetaxel—skin cancer	0.000172	0.000452	CcSEcCtD
Esomeprazole—Abdominal pain—Docetaxel—skin cancer	0.000167	0.000437	CcSEcCtD
Esomeprazole—Body temperature increased—Docetaxel—skin cancer	0.000167	0.000437	CcSEcCtD
Esomeprazole—Hypersensitivity—Docetaxel—skin cancer	0.000155	0.000407	CcSEcCtD
Esomeprazole—Asthenia—Docetaxel—skin cancer	0.000151	0.000396	CcSEcCtD
Esomeprazole—Pruritus—Docetaxel—skin cancer	0.000149	0.000391	CcSEcCtD
Esomeprazole—Diarrhoea—Docetaxel—skin cancer	0.000144	0.000378	CcSEcCtD
Esomeprazole—Dizziness—Docetaxel—skin cancer	0.000139	0.000365	CcSEcCtD
Esomeprazole—Vomiting—Docetaxel—skin cancer	0.000134	0.000351	CcSEcCtD
Esomeprazole—Rash—Docetaxel—skin cancer	0.000133	0.000348	CcSEcCtD
Esomeprazole—Dermatitis—Docetaxel—skin cancer	0.000133	0.000348	CcSEcCtD
Esomeprazole—Headache—Docetaxel—skin cancer	0.000132	0.000346	CcSEcCtD
Esomeprazole—Nausea—Docetaxel—skin cancer	0.000125	0.000328	CcSEcCtD
